Taken together, these findings indicate that CCT2 could be a readout for increased activity of the CCT complex, as our lab showed with breast cancer models (7), and has practical applications as a diagnostic indicator and therapeutic target in cancer. The gene discussed is FLVCR2; the disease is breast cancer.